YY collected references
Khanmohammadi N, Movahedin M, Safari M, Sameni HR, Yousefi B, Jafari B, Zarbakhsh S
43 A similar trend towards a higher risk of unfavourable outcomes was observed in the post hoc analysis of the FIGHT trial
These codes are unique identifiers for medications and are used to describe drugs that are administered in a healthcare setting, such as hospitals, clinics, or doctors offices
Peroxisome proliferator activated receptor delta (PPARdelta) agonist but not PPARalpha corrects carnitine palmitoyl transferase 2 deficiency in human muscle cells
Build the routine while you are still on your full dose, when energy is high and motivation is strong